Buchuan Zhang

1095 Jiefang Ave
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Ablation-induced collagen exposure enables dual-modal nuclear imaging-guided local radionuclide therapy.

Ablation-induced collagen exposure enables dual-modal nuclear imaging-guided local radionuclide therapy.

Journal: Journal of nanobiotechnology
Published: January 15, 2026

Advances in Noninvasive Imaging of Natural Killer Cells.

Advances in Noninvasive Imaging of Natural Killer Cells.

Journal: Molecular pharmaceutics
Published: October 23, 2025

18F-FDG Versus Tissue Factor-Targeted PET/CT in Longitudinal Evaluation of the Formation of DEN-Induced Rat Hepatocellular Carcinoma.

18F-FDG Versus Tissue Factor-Targeted PET/CT in Longitudinal Evaluation of the Formation of DEN-Induced Rat Hepatocellular Carcinoma.

Journal: Molecular pharmaceutics
Published: September 09, 2025

Preclinical evaluation of radiolabeled tissue factor-targeted peptide for theranostics of hepatocellular carcinoma post percutaneous ethanol injection.

Preclinical evaluation of radiolabeled tissue factor-targeted peptide for theranostics of hepatocellular carcinoma post percutaneous ethanol injection.

Journal: Theranostics
Published: August 09, 2024

18F-5-fluoro-aminosuberic acid PET/CT imaging of oxidative-stress features during the formation of DEN-induced rat hepatocellular carcinoma.

18F-5-fluoro-aminosuberic acid PET/CT imaging of oxidative-stress features during the formation of DEN-induced rat hepatocellular carcinoma.

Journal: Theranostics
Published: July 03, 2024

Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer.

Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 04, 2023

Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [177Lu]Lu-DOTAGA.(SA.FAPi)2-Mediated Radiotherapy in Triple-Negative Breast Cancer.

Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [177Lu]Lu-DOTAGA.(SA.FAPi)2-Mediated Radiotherapy in Triple-Negative Breast Cancer.

Journal: Molecular pharmaceutics
Published: April 17, 2023

PET imaging of an optimized anti-PD-L1 probe 68Ga-NODAGA-BMS986192 in immunocompetent mice and non-human primates.

PET imaging of an optimized anti-PD-L1 probe 68Ga-NODAGA-BMS986192 in immunocompetent mice and non-human primates.

Journal: EJNMMI research
Published: March 17, 2022
Showing 1-8 of 8

Last Updated: 09/26/2026